+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID07632365

Study of Induction Chemoimmunotherapy Followed by Chemoradiotherapy and Consolidation Immunotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer

Led by Shanghai Chest Hospital · Updated on 2026-07-23

108

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new treatment approach for patients with unresectable locally advanced non-small cell lung cancer NSCLC. The study is a multicenter phase III trial designed to assess induction chemoimmunotherapy followed by concurrent chemoradiotherapy and consolidation immunotherapy. The purpose is to improve progression-free survival compared to the current standard PACIFIC regimen while maintaining safety. The study has two parts phase I is a single-arm safety lead-in assessing the investigational regimens safety and initial efficacy. If safe, phase II is a randomized trial comparing the investigational treatment against the standard PACIFIC regimen. Induction treatment includes 2 to 4 cycles of platinum-based chemotherapy combined with a PD-L1 inhibitor, followed by concurrent chemoradiotherapy and then consolidation immunotherapy with a PD-L1 inhibitor for up to one year or until disease progression or unacceptable toxicity. Participants undergo assessments for treatment response, safety, and survival outcomes, including progression-free survival and overall survival. Safety is monitored through adverse event tracking, and exploratory analyses evaluate minimal residual disease as a potential marker of treatment response. The total study duration includes treatment periods and follow-up for up to 60 months to assess long-term outcomes.

CONDITIONS

Brief Title

Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

Research Team

W

Wen Yu, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here